Olanzapine

Available EU dossier in development

Offer available for: licensing

Pharmaceutical form and dosage: 5-7,5-10 mg Tablets

Type:

- Generics
- Pharmaceuticals / Therapeutics

Therapeutic target:

Full Description:
Olanzapine dossier:
-New readily available for licensing
-Available: IV/2002
-Stability: 25°C: 24 months + continued, 40°C: 6 months

Availability and Market information:

Status: Development

Market information

Other Market Info:

Patent Information:
Name: Zyprexa
Patent expiration date: > 2006
Patent info: Development of pharmaceuticals which are still under patent is carried out according to EU-requirements in countries with no existing patents or with Bolar-provisions.
We deliver to all countries where the substance and its use are not protected by patents.